{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:59:21Z","timestamp":1788292761144,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.numecd.2022.07.011","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T22:15:46Z","timestamp":1658268946000},"page":"2367-2374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Elevated heart rate as sympathetic biomarker in human obesity"],"prefix":"10.1016","volume":"32","author":[{"given":"Gino","family":"Seravalle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1507-8073","authenticated-orcid":false,"given":"Rita","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-4833","authenticated-orcid":false,"given":"Alessandra","family":"Annaloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Gelfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-6547","authenticated-orcid":false,"given":"Guido","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2022.07.011_bib1","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","article-title":"Influence of heart rate on mortality among persons with hypertension: the Framingham Study","volume":"125","author":"Gillman","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2022.07.011_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.HYP.33.1.44","article-title":"Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure","volume":"33","author":"Benetos","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2022.07.011_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00004872-200105000-00005","article-title":"Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age","volume":"19","author":"Thomas","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2022.07.011_bib4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1001\/archinte.162.20.2313","article-title":"Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension","volume":"162","author":"Palatini","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2022.07.011_bib5","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2022.07.011_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"On behalf of the BEAUTIFUL Investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2022.07.011_bib7","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2011.12.044","article-title":"CHARM Investigators. Association of heart rate and outcomes in a broad spectrum of patIents with chronic heart failure:results from the CHARM (Cardesartan in Heart Failure:Assessment of Reduction in Mortality and morbidity) program","volume":"59","author":"Castagno","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2022.07.011_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ejhf.85","article-title":"Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)","volume":"16","author":"Bohm","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2022.07.011_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/joim.12333","article-title":"Resting heart rate is associated with renal disease outcomes in patients with vascular disease:results of the ONTARGET and TRASCEND studies","volume":"276","author":"Bohm","year":"2015","journal-title":"J Intern Med"},{"issue":"Suppl 19","key":"10.1016\/j.numecd.2022.07.011_bib10","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.5301\/jn.5000229","article-title":"Heart rate, age and the risk of progression of kidney failure in patients with CKD","volume":"25","author":"Zoccali","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.numecd.2022.07.011_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93449-5","article-title":"Elevated resting heart rate as predictor of inflammation and cardiovascular risk in healthy obese individuals","volume":"11","author":"Al-Rashed","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2022.07.011_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","article-title":"The sympathetic nervous system alterations in human hypertension","volume":"116","author":"Grassi","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2022.07.011_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.118.11038","article-title":"Sympathetic nerve traffic activation in essential hypertension and its correlates:systematic reviews and meta-analyses","volume":"72","author":"Grassi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2022.07.011_bib14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ejhf.921","article-title":"The autonomic nervous system as a therapeutic target in heart failure: a scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology","volume":"19","author":"Van Bilsen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2022.07.011_bib15","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/cvr\/cvab222","article-title":"Central and peripheral sympathetic activation in heart failure","volume":"118","author":"Grassi","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2022.07.011_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","article-title":"Early sympathetic activation in the initial clinical stages of chronic renal failure","volume":"57","author":"Grassi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2022.07.011_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/HJH.0000000000002661","article-title":"Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis","volume":"39","author":"Grassi","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2022.07.011_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/HYPERTENSIONAHA.119.12885","article-title":"Sympathetic neural overdrive in obese and overweight state","volume":"74","author":"Grassi","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2022.07.011_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.120.14804","article-title":"Association between the European Society of Cardiology\/European Society of Hypertension heart rate thresholds for cardiovascular risk and neuroadrenergic markers","volume":"76","author":"Grassi","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2022.07.011_bib20","article-title":"Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure","author":"Grassi","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.numecd.2022.07.011_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000003179","article-title":"Sympathetic activation and heart rate tresholds for cardiovascular risk in chronic kidney disease","volume":"40","author":"Grassi","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2022.07.011_bib22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/10826079608006322","article-title":"Determination of catecholamines in human plasma by HPLC with electrochemical detection","volume":"19","author":"Javidan","year":"1996","journal-title":"J Liq Chrom Relat Tech"},{"key":"10.1016\/j.numecd.2022.07.011_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.numecd.2014.07.009","article-title":"The role of insulin resistance in the association between body fat and autonomic function","volume":"25","author":"Hillebrand","year":"2014","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2022.07.011_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.numecd.2022.07.011_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0894-7317(96)90019-X","article-title":"Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography","volume":"9","author":"Park","year":"1996","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.numecd.2022.07.011_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/sleep\/22.5.667","article-title":"Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research","volume":"22","author":"Report of an American Academy of Sleep Medicine Task Force","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.numecd.2022.07.011_bib27","first-page":"559","article-title":"Indications and standards for cardiopulmonary sleep studies","volume":"139","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.numecd.2022.07.011_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/sleep\/25.8.8","article-title":"Sleep heart health study (SHHS) research Group.Short-term variability of respiration and sleep during unattended non laboratory polysomnography. The sleep heart health study","volume":"25","author":"Quan","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.numecd.2022.07.011_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.numecd.2008.09.008","article-title":"Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity","volume":"19","author":"Grassi","year":"2009","journal-title":"Nutr Met Cardiov Dis"},{"key":"10.1016\/j.numecd.2022.07.011_bib30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1152\/physrev.1990.70.4.963","article-title":"Overflow of catecholamine neurotransmitters to the circulation: source, fate and function","volume":"70","author":"Esler","year":"1990","journal-title":"Physiol Rev"},{"key":"10.1016\/j.numecd.2022.07.011_bib31","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/00004872-199816110-00010","article-title":"Heart rate as marker of sympathetic activity","volume":"16","author":"Grassi","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2022.07.011_bib32","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/01.CIR.96.10.3423","article-title":"Regional sympathetic nervous activity and oxygen consuption in obese normotensive human subjects","volume":"96","author":"Vaz","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2022.07.011_bib33","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-199917080-00012","article-title":"Neural mechanisms in obesity-related hypertension","volume":"17","author":"Rumantir","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2022.07.011_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.numecd.2007.01.004","article-title":"Cardiovascular risk and adrenergic overactivity in the metabolic syndrome","volume":"17","author":"Grassi","year":"2007","journal-title":"Nutr Metabol Cardiovasc Dis"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475322003003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475322003003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:22:56Z","timestamp":1760545376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475322003003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0939475322003003"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2022.07.011","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated heart rate as sympathetic biomarker in human obesity","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2022.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}